The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy.
Hao ZhangHuihui ChiLiangzhe XieYue SunHonglei LiuXiaobing ChengJunna YeHui ShiQiongyi HuJianfen MengZhuochao ZhouJialin TengChengde YangYutong SuPublished in: Advances in rheumatology (London, England) (2023)
Serum hs-cTnI testing may play a role in screening for cardiac involvement in IIM patients. Abnormal levels of serum hs-cTnI were associated with increased disease activity and poor prognosis.
Keyphrases
- poor prognosis
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- long non coding rna
- left ventricular
- ejection fraction
- newly diagnosed
- rheumatoid arthritis patients
- ankylosing spondylitis
- chronic kidney disease
- peritoneal dialysis
- oxidative stress
- prognostic factors
- juvenile idiopathic arthritis
- heart failure
- muscular dystrophy
- duchenne muscular dystrophy